Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
17.74
+1.13 (6.80%)
At close: Dec 19, 2025, 4:00 PM EST
17.89
+0.15 (0.85%)
After-hours: Dec 19, 2025, 7:53 PM EST
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $701.30M in the quarter ending September 30, 2025, with 3.91% growth. This brings the company's revenue in the last twelve months to $2.76B, up 1.88% year-over-year. In the year 2024, Fortrea Holdings had annual revenue of $2.70B, down -5.14%.
Revenue (ttm)
$2.76B
Revenue Growth
+1.88%
P/S Ratio
0.58
Revenue / Employee
$171,210
Employees
16,120
Market Cap
1.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.70B | -146.10M | -5.14% |
| Dec 31, 2023 | 2.84B | 5.50M | 0.19% |
| Dec 31, 2022 | 2.84B | -220.50M | -7.21% |
| Dec 31, 2021 | 3.06B | 477.20M | 18.49% |
| Dec 31, 2020 | 2.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
FTRE News
- 9 days ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery - GlobeNewsWire
- 17 days ago - Fortrea Holdings Inc. (FTRE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 25 days ago - Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences - GlobeNewsWire
- 26 days ago - Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand - GlobeNewsWire
- 4 weeks ago - Fortrea Appoints Agnieszka Gallagher as General Counsel - GlobeNewsWire
- 5 weeks ago - Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer - GlobeNewsWire
- 6 weeks ago - Fortrea Holdings Inc. (FTRE) Q3 2025 Earnings Call Transcript - Seeking Alpha